Corrigendum to "Comprehensive in-silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small molecular inhibitors for the treatment of Cholangiocarcinoma" [Comput. Biol. Med. 166 (2023) 107572].